Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding Zepbound and Mounjaro.

I feel like they have a larger and more visible target in the telehealth and compounding pharmacies. The avg person isn't going to be willing to do "research," but tell them that an FDA approved pharmacy prepared the drugs, and they will throw their money at it to get a deal on the product...
 
sherwood.news

Compounding pharmacy says Eli Lilly’s cease and desist letter means “nothing”

Some compounding pharmacies have kept selling GLP-1s that they say are “personalized” or “tailored” for patients’ needs....
sherwood.news sherwood.news

...There appears to be a legal challenge brewing between drugmakers and compounding pharmacies, which may be able to sue for patent infringement. That type of litigation is risky because if a judge were to rule against the drugmakers, it could risk their patent and the billions they make selling those drugs...
 
Last edited:
StopCraving_12 said:
Strive and Empower supply tirzepatide to popular telehealth sites, including Lavender Sky Health and Mochi Health. The companies didn’t immediately respond to CNBC’s requests for comment.

Click to expand...
This is the same pharmacy that my medical facility goes through for compounded medications. But right now they're able to get away with doing this, because they don't use the exact same dosaging plus they add glycine and B12. It's not just Tirzepatide
 
Calm Logic said:
sherwood.news

Compounding pharmacy says Eli Lilly’s cease and desist letter means “nothing”

Some compounding pharmacies have kept selling GLP-1s that they say are “personalized” or “tailored” for patients’ needs....
sherwood.news sherwood.news

...There appears to be a legal challenge brewing between drugmakers and compounding pharmacies, which may be able to sue for patent infringement. That type of litigation is risky because if a judge were to rule against the drugmakers, it could risk their patent and the billions they make selling those drugs...
Click to expand...
I just have to say that, the drugs ARE personalized AND tailored to patients needs, in such a way that personally, not everyone can afford EL's prices. So yes, in a way besides the extra vitamins or glycine, that might not work for compounding pharmacies to continue compounding, the price works for most. This helps, NO, this can save thousands of people. Unfortunately, there is a patent, but not in pricing. EL has to do better with their pricing. When doctors tell you that , unless you lose weight or you have less than 7 years to live, because your heart is going to stop working for you(or other types of serious health issues besides being diabetic) and your insurance doesn't want to cover such outrageous prices for the med, the price should be tailored as well. If EL can't do it, there are compounding pharmacies that will! This upsets me as it does for most. I'm so happy that I found everyone here on this forum. This is one of the best decisions that I made!
 
www.menshealth.com

The Government Crackdown on Off-Brand Ozempic Has Begun. Here’s What That Means for You.

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs for millions of people.
www.menshealth.com www.menshealth.com

...Dr. Ghosh anticipates that the pharma companies and their stacked legal teams, rather than the FDA, will end up driving how long those personalized doses can remain available. “In the next year, there’s probably going to be this back-and-forth dance that’s happening between the pharmaceutical companies and the compounding pharmacies, where the compounding pharmacies continue to make adjustments and look for loopholes, and then the pharmaceutical companies try to change the policies to close loopholes,” she explains. “I would guess eventually the compounds [including the personalized doses] won’t be available. We just don’t know what that timeline looks like.”

She went on to say that during the period when this is all hashed out, other medications will likely be introduced that could upend everything…again. On April 17, Eli Lilly announced that its drug orforglipron became the first oral GLP-1 to successfully complete a Phase 3 trial for safety and efficacy for people with diabetes and obesity. There’s an existing semaglutide oral tablet available from Novo Nordisk sold under the brand name Rybelsus, but Dr. Ghosh says the injectable GLP-1s out there remain far superior for blood sugar control and weight loss because of the way they’re metabolized. This new oral medication from Eli Lilly, which also comes with no food or drink restrictions, could change that.

That’s a good thing—because despite all the changes in this landscape, the demand for effective, affordable medications that help with weight loss and improve overall health isn’t going anywhere.
 
keangkong said:
I have a feeling that SRY, which has been indicted for selling opioids in the US, is not worried about being sued by Eli Lilly.
Click to expand...
I'm also guessing they won't come after my beautiful Chinese contact Lotus Blossom who is actually a 60 year old Phillipino man who wears an eye patch, smokes cigars and reeks of cat piss and brandy.
 
You must log in or register to reply here.

Trending Topics

Latest Posts

Forum Statistics

Threads
18,497
Posts
192,420
Members
61,794
Newest
Fish.0550
Back
Top Bottom